Stay updated on Efficacy of LFG316 in PNH Patients Clinical Trial
Sign up to get notified when there's something new on the Efficacy of LFG316 in PNH Patients Clinical Trial page.

Latest updates to the Efficacy of LFG316 in PNH Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ClinicalTrials.gov record for Novartis’s PNH study now displays study details, eligibility criteria, treatment plan, outcomes, locations, record dates, and supporting documents instead of an error page.SummaryDifference54%

- Check15 days agoChange DetectedThe footer revision number changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner was added announcing that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” across its content.SummaryDifference1%

- Check29 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe revision label in the ClinicalTrials.gov footer changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check43 days agoChange DetectedThe clinical trial record, including its study details and results, is no longer displayed; the page shows a 403 Forbidden message instead.SummaryDifference19%

Stay in the know with updates to Efficacy of LFG316 in PNH Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of LFG316 in PNH Patients Clinical Trial page.